Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to investigate whether differences in atorvastatin
metabolite ratios might have a positive or negative predictive value in diagnosing
atorvastatin muscle toxicity. A muscle biopsy is also collected and investigated.